E3 binds to dsRNA and prevents activation of PKR [33, 34], whereas K3 encodes an S1 XMU-MP-1 datasheet domain that is homologous to the N-terminus of eIF2α and inhibits activated PKR by binding to the kinase domain and acting as a pseudosubstrate inhibitor of PKR [18, 35, 36]. Interestingly, most ranaviruses encode a C646 concentration protein with an S1 domain, which is related to the S1 domain of eIF2α and K3 and is referred to as a viral homolog of eIF2α or vIF2α. In contrast to K3, which only possesses the S1 domain, vIF2α proteins contain a C-terminal extension of between 165 to 190 amino acids, for which no sequence homology to any other proteins was described. It was previously speculated that vIF2α in analogy to
K3 might be an inhibitor of PKR and might therefore play an important role in the pathogenesis of ranaviruses [37–39]. Herein, using a heterologous yeast assay system, we describe the characterization of vIF2α as an inhibitor of human and zebrafish AZD4547 solubility dmso PKR. Results We present three lines of evidence that the C-terminus of vIF2α is actually homologous to the helical and parts of the C-terminal domains of eIF2α. Firstly, we performed PSI-BLAST searches with vIF2α from ATV and RCV-Z. During the first iteration, sequence similarity for regions
spanning amino acids 5-118 of ATV-vIF2α with the S1 and helical domains eIF2α from multiple eukaryotes was noted. During the second iteration, this region of similarity to eIF2α was extended to amino acid position 253 of vIF2α. Secondly, multiple sequence
alignments including Urocanase vIF2α from many ranaviruses and eIF2α from a diverse set of eukaryotes showed conservation of amino acids outside the S1 domain: 8 amino acids are 100% conserved among the sequences (Figure 1, red background; Cys99, Glu118, Leu160, Ala177, Gly192, Ala199, Val220 and Gly253). Moreover, conservative amino acid differences are present at 22 positions outside the S1 domain (Figure 1, green background). At many other positions, amino acids that are identical to the ones found in vIF2α are present in a subset of eIF2α sequences (Figure 1, light blue background). While the multiple sequence alignment reveals sequence homology between vIF2α and eIF2α throughout the reading frame, sequence similarity is highest within the S1 domain, with the highest levels of sequence identity surrounding strands β4 and β5 (Val74 – Leu88 in vIF2α) as previously described [38, 39]. Interestingly, in VACV K3 this region was previously shown to be important for PKR inhibition [40]. Thirdly, secondary structure prediction with ATV and RCV-Z vIF2α resulted in predicted β-sheets and α-helices that coincide very well with the solved structural features observed in the NMR structure of human eIF2α [41]. These observations indicate that the middle and C-terminal parts of vIF2α are homologous to the helical and C-terminal domains, respectively, of eIF2α.